» Articles » PMID: 12393531

Hypoxia-inducible Factor-1 and Hypoxia Response Elements Mediate the Induction of Plasminogen Activator Inhibitor-1 Gene Expression by Insulin in Primary Rat Hepatocytes

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Oct 24
PMID 12393531
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of the plasminogen activator inhibitor-1 (PAI-1) gene is enhanced by insulin both in vivo and in various cell types. Because insulin exerts a number of its biologic activities via the phosphatidylinositol 3-kinase and protein kinase B (PI3K/PKB) signaling pathway, it was the aim of the present study to investigate the role of the PI3K/PKB pathway in the expression of the PAI-1 gene and to identify the insulin responsive promoter sequences. It was shown that the induction of PAI-1 mRNA and protein expression by insulin and mild hypoxia could be repressed by the PI3K inhibitor wortmannin. Overexpression of a constitutively active PKB led to induction of PAI-1 mRNA expression and of luciferase (Luc) activity from a gene construct containing 766 bp of the rat PAI-1 promoter. Mutation of the hypoxia response elements (HRE-1 and HRE-2) in rat PAI-1 promoter, which could bind hypoxia inducible factor-1 (HIF-1), abolished the induction of PAI-1 by insulin and PKB. Insulin and the constitutive active PKB also induced Luc expression in cells transfected with the pGl3EPO-HRE Luc construct, containing 3 copies of the HRE from the erythropoietin gene in front of the SV40 promoter. Furthermore, insulin and the active PKB enhanced all 3 HIF alpha-subunit protein levels and HIF-1 DNA-binding activity, as shown by electrophoretic mobility shift assays (EMSAs). Thus, the insulin-dependent activation of the PAI-1 gene expression can be mediated via the PI3K/PKB pathway and the transcription factor HIF-1 binding to the HREs in the PAI-1 gene promoter.

Citing Articles

Biocompatible Nanocomposites for Postoperative Adhesion: A State-of-the-Art Review.

Kargozar S, Gorgani S, Nazarnezhad S, Wang A Nanomaterials (Basel). 2024; 14(1).

PMID: 38202459 PMC: 10780749. DOI: 10.3390/nano14010004.


Protein kinase B/AKT phosphorylates hypoxia-inducible factor-3α1 in response to insulin, promoting cell growth and migration.

Nguyen T, Bergmann U, Kietzmann T, Mennerich D Front Cell Dev Biol. 2023; 11:1250000.

PMID: 38020884 PMC: 10665492. DOI: 10.3389/fcell.2023.1250000.


Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes.

Dai W, Zhang H, Lund H, Zhang Z, Castleberry M, Rodriguez M Science. 2023; 381(6661):eadh5207.

PMID: 37651538 PMC: 10697821. DOI: 10.1126/science.adh5207.


Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain.

Bui B, Nguyen P, Lee K, Cho J Cancers (Basel). 2022; 14(24).

PMID: 36551540 PMC: 9775408. DOI: 10.3390/cancers14246054.


Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of Diabetes.

Iacobini C, Vitale M, Haxhi J, Pesce C, Pugliese G, Menini S Antioxidants (Basel). 2022; 11(11).

PMID: 36358555 PMC: 9686572. DOI: 10.3390/antiox11112183.